Chuck Grassley - How to Avoid a Heart Attack

NEW YORK (Reuters) - U.S. regulators are considering ending a safety study on GlaxoSmithKline's diabetes drug Avandia, the Wall Street Journal reported on Sunday, saying the move could also jeopardize the drug's presence in the U.S. market.Avandia has been in the spotlight ...

Senator Chuck Grassley (R-IA) is investigating potential financial conflicts of interest among cardiologists associated with Columbia University.

In his letter to the Government Accountability Office [GAO], Sen. Grassley asks for an investigation into FDA's use of surrogates for product approval and whether FDA has appropriately followed up drugs approved initially based on surrogate markers. It is not a proven ...

U.S. Drug Agency's Own Study Showed Diabetes Drug's Risks, Senator SaysThe government's own evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might ...

The government's own preliminary evaluation of the diabetes pill Avandia confirms the heart risks reported in a study earlier this week and suggests that as many as 60,000 to 100,000 heart attacks might be linked to its use since it came on ...

Topic: Chuck Grassley

FDA mulls killing Avandia safety study: report

Summary:

Cardiologists Come Under the Glare of a Senate Inquiry

Grassley Seeks GAO Input on Surrogates and Postmarketing Follow Up by FDA

FDA study said to show Avandia risk

U.S. drug agency's own study showed diabetes drug's risks, senator says

Photo Gallery

From Around the Web

Video Gallery

Follow this Topic with...